<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
xmlns:EMSArticle="http://webdoc.advanstar.com/rss/module/EMSArticle"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/servlet/ophthalmologytimeseurope_full.rss">
    <title>Ophthalmology Times Europe</title>

    <link>http://www.oteurope.com/ophthalmologytimeseurope</link>

    <description>ophthalmology news, features, events and interviews in cataract, refractive, glaucoma, retina and much
    more.</description>

    <items>
      <rdf:Seq>
        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Toric-IOL-improves-patient-quality-of-life/ArticleStandard/Article/detail/813261?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Macular-thickness-increases-after-cataract-surgery/ArticleStandard/Article/detail/813260?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Corneal-degeneration-is-more-common-in-white-women/ArticleStandard/Article/detail/813257?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Increased-intake-of-carotenoids-and-fish-oil-doesn/ArticleStandard/Article/detail/813254?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Cornea/Visual-acuity-poorly-linked-to-GT-after-DSAEK/ArticleStandard/Article/detail/812641?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/RDO-patient-pathway-improves-operative-rates-in-ca/ArticleStandard/Article/detail/812639?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Stepladder-technique-successful-for-malignant-glau/ArticleStandard/Article/detail/812637?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/DME-patient-treated-with-Iluvien/ArticleStandard/Article/detail/812636?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Combined-scleral-buckle-and-BGI-is-effective/ArticleStandard/Article/detail/812096?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Cornea/KLAL-significantly-affected-by-adverse-events/ArticleStandard/Article/detail/812095?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Piggyback-toric-IOL-effective-for-astigmatism/ArticleStandard/Article/detail/812086?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Iluvien-for-DME-available-in-UK/ArticleStandard/Article/detail/812085?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Parkinsons-linked-to-retinal-changes/ArticleStandard/Article/detail/811399?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Repeatability-of-internal-aberrometry/ArticleStandard/Article/detail/812863?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Focal-photocoagulation-less-invasive-for-microaneu/ArticleStandard/Article/detail/811397?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Pars-plana-vitrectomy-useful-for-post-injection-en/ArticleStandard/Article/detail/812869?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Eye-screening-in-maternity-wards/ArticleStandard/Article/detail/812860?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Treatment-for-ME-secondary-to-CRVO/ArticleStandard/Article/detail/812871?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Paediatric-treatments-improving/ArticleStandard/Article/detail/812866?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Faster-recovery-after-25G-than-20G-vitrectomy/ArticleStandard/Article/detail/812867?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/INTREPID-identifies-best-responders/ArticleStandard/Article/detail/812865?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Canaloplasty-an-option-after-failed-trabeculectomy/ArticleStandard/Article/detail/812862?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Surveying-PRN-strategy-compliance/ArticleStandard/Article/detail/812861?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Excimer-laser-procedure-holds-appeal-in-younger-pa/ArticleStandard/Article/detail/812872?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Canaloplasty-An-alternative-to-filtrating-surgery/ArticleStandard/Article/detail/812868?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/MIOL-implantation-in-paediatric-cases/ArticleStandard/Article/detail/812873?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Accuracy-of-wavefront-aberrometry-in-cataract-pati/ArticleStandard/Article/detail/812864?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Product-Profiles/ArticleStandard/Article/detail/812870?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Excellent-visual-outcomes-in-cataract-surgery/ArticleStandard/Article/detail/811396?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Retina/NICE-recommends-ranibizumab-for-NHS/ArticleStandard/Article/detail/811395?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Cornea/FS-laer-assisted-intrastomal-arcuate-keratotomy-a-/ArticleStandard/Article/detail/810803?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Dry+Eye/New-financing-round-for-dry-eye-portfolio/ArticleStandard/Article/detail/811563?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/POAG-surgical-outcomes-affected-by-DM/ArticleStandard/Article/detail/810795?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Bevacizumab-not-recommended-for-NAION/ArticleStandard/Article/detail/810794?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Global-agreement-signed/ArticleStandard/Article/detail/810793?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Bevacizumab-regresses-abnormal-diabetic-neovascula/ArticleStandard/Article/detail/810239?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Pressure-sensitive-lens-tolerable-and-safe-for-24-/ArticleStandard/Article/detail/810238?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Multifocal-diffractive-add-on-IOL-suitable-alterna/ArticleStandard/Article/detail/810229?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Unoprostone-in-Phase-III-study-for-RP/ArticleStandard/Article/detail/810218?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Big-bubble-size-can-be-safely-increased/ArticleStandard/Article/detail/809095?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/PDT-reduces-choroidal-thickness/ArticleStandard/Article/detail/809094?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Pupil-size-and-axial-length-affect-near-vision/ArticleStandard/Article/detail/809093?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Trabectome-alternative-for-glaucoma-surgery/ArticleStandard/Article/detail/809092?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/MGD-management-needed-for-ocular-prosthesis-wearer/ArticleStandard/Article/detail/808937?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Multicomponent-IOL-provides-excellent-vision/ArticleStandard/Article/detail/808935?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Event+List/119th-SFO-Congress/ArticleStandard/Article/detail/809056?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Paediatrics/BTA-injections-can-treat-infantile-esotropia/ArticleStandard/Article/detail/808936?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Congress-of-the-French-Society-of-Ophthalmology-md/ArticleStandard/Article/detail/809058?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Improving-vitreoretinal-surgery/ArticleStandard/Article/detail/809329?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Limiting-IOP-rise-in-laser-cataract-procedures/ArticleStandard/Article/detail/809335?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+features/Mastering-corneal-inlays/ArticleStandard/Article/detail/809319?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Product-Profiles/ArticleStandard/Article/detail/809888?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Anti-VEGF-therapy-for-the-treatment-of-glaucoma/ArticleStandard/Article/detail/809312?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Inlay-promising-for-presbyopia/ArticleStandard/Article/detail/809325?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Surgical-compensation-of-presbyopia-with-a-corneal/ArticleStandard/Article/detail/809338?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+features/Femto-phaco-vs-traditional-phaco/ArticleStandard/Article/detail/809321?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Retina+features/ME-treatment-benefits-according-to-duration-of-BRV/ArticleStandard/Article/detail/809332?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Preservative-free-preparation-may-improve-adherenc/ArticleStandard/Article/detail/809315?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+features/Fixed-combinations-in-POAG-and-OHT-patients/ArticleStandard/Article/detail/809316?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/High-resolution-aberrometry/ArticleStandard/Article/detail/809342?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Fenretinide-has-potential-for-GA/ArticleStandard/Article/detail/808938?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Efficacy-of-LCS-compared-with-manual-techniques/ArticleStandard/Article/detail/809317?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Cornea/Mushroom-configuration-can-perform-corneal-cuts/ArticleStandard/Article/detail/808645?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Risk-factors-for-esotropia-reoperation-revealed/ArticleStandard/Article/detail/808643?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Eye-viscosity-increases-with-age/ArticleStandard/Article/detail/808642?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Monitoring-glaucoma-progression-with-SLP/ArticleStandard/Article/detail/808646?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Caution-needed-for-full-correction-in-low-astigmat/ArticleStandard/Article/detail/808012?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/ICRS-depth-less-than-expected-using-OCT/ArticleStandard/Article/detail/808005?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/EyeTechCare-secures-third-round-of-funding-for-Eye/ArticleStandard/Article/detail/808004?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Retinal-implant-provides-artificial-sight-for-the-/ArticleStandard/Article/detail/808003?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Laser-confocal-imaging-useful-for-AMD/ArticleStandard/Article/detail/807451?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Vision-UK-2013-speakers-announced/ArticleStandard/Article/detail/807450?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Aciex-and-Portola-enter-into-research-agreement/ArticleStandard/Article/detail/807447?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/POAG-detection-successful-with-tract-based-spatial/ArticleStandard/Article/detail/807446?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Cornea/OSST-should-be-closely-monitored-for-rejection/ArticleStandard/Article/detail/806766?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/ECD-not-linked-to-CCT-in-keratoconus/ArticleStandard/Article/detail/806762?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/PED-volume-and-area-changes-could-indicate-retreat/ArticleStandard/Article/detail/806761?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Supplements/Products-in-Practice-2013/ArticleStandard/Article/detail/807303?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/High-patient-satisfaction-for-ocular-hypotensives/ArticleStandard/Article/detail/806759?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Moving-forwards-noninvasive-imaging-of-the-eye/ArticleStandard/Article/detail/807271?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/SMILE-techniques-less-disruptive/ArticleStandard/Article/detail/807276?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Devices-Adapted-to-CMICS-phaco/ArticleStandard/Article/detail/807278?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/MICS-and-TSV-Combined/ArticleStandard/Article/detail/807279?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Scheimpflug-tomographers-Are-they-precise/ArticleStandard/Article/detail/807275?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/A-genetic-algorithm-to-predict-the-risk-of-advance/ArticleStandard/Article/detail/807281?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Topography-guided-ablation-for-myopia-and-myopic-a/ArticleStandard/Article/detail/807282?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/En-face-OCT-imaging-takes-shape/ArticleStandard/Article/detail/807274?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Comparison-of-PCO-Between-a-1--and-3-Piece-MICS-IO/ArticleStandard/Article/detail/807280?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Retro-foveolar-choroidal-thickness-is-thinner-in-a/ArticleStandard/Article/detail/807277?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Retinal-layer-thickness-is-decreased-in-glaucomato/ArticleStandard/Article/detail/807273?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Product-Profiles/ArticleStandard/Article/detail/807272?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/A-P-method-may-calculate-IOL-power/ArticleStandard/Article/detail/806066?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Aflibercept-injections-improves-VA-in-CRVO-patient/ArticleStandard/Article/detail/806065?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Vision-UK-2013-call-for-papers/ArticleStandard/Article/detail/806105?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Clobetasone-butyrate-safe-and-effective-for-SS/ArticleStandard/Article/detail/806064?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Coats-disease-treated-with-bevacizumab/ArticleStandard/Article/detail/806063?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Loteprednol-etabonate-controls-inflammation-and-IO/ArticleStandard/Article/detail/805647?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Beclomethasone-nasal-spray-doesnt-increase-IOP/ArticleStandard/Article/detail/805646?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/ICG-enhanced-TTT-effectively-treats-retinoblastoma/ArticleStandard/Article/detail/805645?ref=25" />

        <rdf:li
        resource="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Strategic-alliance-for-clinical-research-announced/ArticleStandard/Article/detail/805644?ref=25" />
      </rdf:Seq>
    </items>

    <dc:date>2013-05-25T11:41:59Z</dc:date>
  </channel>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Toric-IOL-improves-patient-quality-of-life/ArticleStandard/Article/detail/813261?ref=25">

    <title>Toric IOL improves patient quality of life</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Toric-IOL-improves-patient-quality-of-life/ArticleStandard/Article/detail/813261?ref=25</link>

    <description>Implantation of a toric IOL results in improved patient quality of life and better visual, refractive
    and aberrometric results, states a new investigation.</description>

    <dc:date>2013-05-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/202013/813261null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Macular-thickness-increases-after-cataract-surgery/ArticleStandard/Article/detail/813260?ref=25">

    <title>Macular thickness increases after cataract surgery</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Cataract+News/Macular-thickness-increases-after-cataract-surgery/ArticleStandard/Article/detail/813260?ref=25</link>

    <description>Macular thickness significantly increases up to six months after uncomplicated cataract surgery,
    according to an investigation featured in the journal Eye.</description>

    <dc:date>2013-05-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/202013/813260null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Corneal-degeneration-is-more-common-in-white-women/ArticleStandard/Article/detail/813257?ref=25">

    <title>Corneal degeneration is more common in white women</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Corneal-degeneration-is-more-common-in-white-women/ArticleStandard/Article/detail/813257?ref=25</link>

    <description>Peripheral hypertrophic subepithelial corneal degeneration is an uncommon disorder that occurs mostly
    in white women with a distinct phenotype, claims a study in the journal Ophthalmology.</description>

    <dc:date>2013-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/202013/813257null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Increased-intake-of-carotenoids-and-fish-oil-doesn/ArticleStandard/Article/detail/813254?ref=25">

    <title>Increased intake of carotenoids and fish oil doesn't reduce AMD risk further</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Increased-intake-of-carotenoids-and-fish-oil-doesn/ArticleStandard/Article/detail/813254?ref=25</link>

    <description>Increased oral supplementation of carotenoids (lutein and zeaxanthin) and omega-3 fatty acids, found
    in fish oil, does not reduce the risk of AMD progression further to the original AREDS formulation, claims the
    latest results of the Age-Related Eye Disease Study (AREDS2).</description>

    <dc:date>2013-05-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/202013/813254null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Cornea/Visual-acuity-poorly-linked-to-GT-after-DSAEK/ArticleStandard/Article/detail/812641?ref=25">

    <title>Visual acuity poorly linked to GT after DSAEK</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Cornea/Visual-acuity-poorly-linked-to-GT-after-DSAEK/ArticleStandard/Article/detail/812641?ref=25</link>

    <description>Visual acuity poorly correlates to graft thickness (GT) in patients who underwent descemet stripping
    automated endothelial keratoplasty (DSAEK), states a paper in the journal Cornea.</description>

    <dc:date>2013-05-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812641null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/RDO-patient-pathway-improves-operative-rates-in-ca/ArticleStandard/Article/detail/812639?ref=25">

    <title>RDO patient pathway improves operative rates in cataracts</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/RDO-patient-pathway-improves-operative-rates-in-ca/ArticleStandard/Article/detail/812639?ref=25</link>

    <description>Operative rates for cataract surgery are higher for the refined direct optometrist (RDO) patient
    pathway, compared to the GP pathway, reveals a recent investigation in the UK.</description>

    <dc:date>2013-05-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812639null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Stepladder-technique-successful-for-malignant-glau/ArticleStandard/Article/detail/812637?ref=25">

    <title>Stepladder technique successful for malignant glaucoma</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Stepladder-technique-successful-for-malignant-glau/ArticleStandard/Article/detail/812637?ref=25</link>

    <description>Malignant glaucoma can be successfully managed using the stepladder technique, including timely and
    appropriate interventions, claims a paper in the journal Ophthalmology.</description>

    <dc:date>2013-05-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812637null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/DME-patient-treated-with-Iluvien/ArticleStandard/Article/detail/812636?ref=25">

    <title>DME patient treated with Iluvien</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/DME-patient-treated-with-Iluvien/ArticleStandard/Article/detail/812636?ref=25</link>

    <description>Iluvien has been used to treat a diabetic macular oedema (DME) patient in the UK since the product
    became commercially available, it was revealed in a press release this week.</description>

    <dc:date>2013-05-13T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812636null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Combined-scleral-buckle-and-BGI-is-effective/ArticleStandard/Article/detail/812096?ref=25">

    <title>Combined scleral buckle and BGI is effective</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Combined-scleral-buckle-and-BGI-is-effective/ArticleStandard/Article/detail/812096?ref=25</link>

    <description>Combined scleral buckle and Baerveldt glaucoma implantation (BGI) is effective for managing coexisting
    glaucoma and retinal detachment.</description>

    <dc:date>2013-05-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/182013/812096null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Cornea/KLAL-significantly-affected-by-adverse-events/ArticleStandard/Article/detail/812095?ref=25">

    <title>KLAL significantly affected by adverse events</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Cornea/KLAL-significantly-affected-by-adverse-events/ArticleStandard/Article/detail/812095?ref=25</link>

    <description>Keratolimbal allograft (KLAL) transplantation is affected by adverse events including immunologic
    rejections, chronic ocular surface exposure and graft-related complications, according to a study featured in
    Cornea.</description>

    <dc:date>2013-05-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/182013/812095null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Piggyback-toric-IOL-effective-for-astigmatism/ArticleStandard/Article/detail/812086?ref=25">

    <title>Piggyback toric IOL effective for astigmatism</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Piggyback-toric-IOL-effective-for-astigmatism/ArticleStandard/Article/detail/812086?ref=25</link>

    <description>Implanting a customized primary or a secondary piggyback toric IOL post-penetrating keratoplasty (PK)
    is effective for astigmatism, claims a paper in Eye.</description>

    <dc:date>2013-05-07T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/182013/812086null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Iluvien-for-DME-available-in-UK/ArticleStandard/Article/detail/812085?ref=25">

    <title>Iluvien for DME available in UK</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Iluvien-for-DME-available-in-UK/ArticleStandard/Article/detail/812085?ref=25</link>

    <description>Iluvien, an intravitreal implant, is now available as a treatment for chronic diabetic macular oedema
    (DME) in the UK.</description>

    <dc:date>2013-05-06T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/182013/812085null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Parkinsons-linked-to-retinal-changes/ArticleStandard/Article/detail/811399?ref=25">

    <title>Parkinsons linked to retinal changes</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Parkinsons-linked-to-retinal-changes/ArticleStandard/Article/detail/811399?ref=25</link>

    <description>Parkinsons disease (PD) is associated with retinal nerve fibre layer (RNFL) loss and retinal thinning
    and can be detected by Fourier-domain OCT, claims a new study.</description>

    <dc:date>2013-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/172013/811399null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Repeatability-of-internal-aberrometry/ArticleStandard/Article/detail/812863?ref=25">

    <title>Repeatability of internal aberrometry</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Repeatability-of-internal-aberrometry/ArticleStandard/Article/detail/812863?ref=25</link>

    <description>Caution should be taken when considering procedures that rely on these measurements</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812863null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Focal-photocoagulation-less-invasive-for-microaneu/ArticleStandard/Article/detail/811397?ref=25">

    <title>Focal photocoagulation less invasive for microaneurysms</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Focal-photocoagulation-less-invasive-for-microaneu/ArticleStandard/Article/detail/811397?ref=25</link>

    <description>Focal photocoagulation may be a less invasive method for the treatment of microaneurysms, according to
    a paper published in the journal Retina.</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/172013/811397null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Pars-plana-vitrectomy-useful-for-post-injection-en/ArticleStandard/Article/detail/812869?ref=25">

    <title>Pars plana vitrectomy useful for post-injection endophthalmitis</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Pars-plana-vitrectomy-useful-for-post-injection-en/ArticleStandard/Article/detail/812869?ref=25</link>

    <description>If improvement is not seen after 24 hours vitrectomy should be considered</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812869null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Eye-screening-in-maternity-wards/ArticleStandard/Article/detail/812860?ref=25">

    <title>Eye screening in maternity wards</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Eye-screening-in-maternity-wards/ArticleStandard/Article/detail/812860?ref=25</link>

    <description>Evaluation demonstrates efficacy of routine screening on new borns</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812860null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Treatment-for-ME-secondary-to-CRVO/ArticleStandard/Article/detail/812871?ref=25">

    <title>Treatment for ME secondary to CRVO</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Treatment-for-ME-secondary-to-CRVO/ArticleStandard/Article/detail/812871?ref=25</link>

    <description>Six-month results from the GALILEO study show promise for VEGF Trap-Eye</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812871null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Paediatric-treatments-improving/ArticleStandard/Article/detail/812866?ref=25">

    <title>Paediatric treatments improving</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Paediatric-treatments-improving/ArticleStandard/Article/detail/812866?ref=25</link>

    <description>Advances offer better understanding of allergic diseases, remedies, relief for children</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812866null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Faster-recovery-after-25G-than-20G-vitrectomy/ArticleStandard/Article/detail/812867?ref=25">

    <title>Faster recovery after 25G than 20G vitrectomy</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Faster-recovery-after-25G-than-20G-vitrectomy/ArticleStandard/Article/detail/812867?ref=25</link>

    <description>But comparable functional and anatomical results in diabetic retinopathy patients</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812867null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/INTREPID-identifies-best-responders/ArticleStandard/Article/detail/812865?ref=25">

    <title>INTREPID identifies 'best responders'</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/INTREPID-identifies-best-responders/ArticleStandard/Article/detail/812865?ref=25</link>

    <description>Fewer anti-VEGF injections among benefits of stereotactic radiotherapy for wet AMD</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812865null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Canaloplasty-an-option-after-failed-trabeculectomy/ArticleStandard/Article/detail/812862?ref=25">

    <title>Canaloplasty an option after failed trabeculectomy</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Canaloplasty-an-option-after-failed-trabeculectomy/ArticleStandard/Article/detail/812862?ref=25</link>

    <description>If initial trabeculectomy has failed, canaloplasty can be an option, according to Dr
    Brusini</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812862null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Surveying-PRN-strategy-compliance/ArticleStandard/Article/detail/812861?ref=25">

    <title>Surveying PRN strategy compliance</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Surveying-PRN-strategy-compliance/ArticleStandard/Article/detail/812861?ref=25</link>

    <description>Strict monthly follow-up procedures should be implemented to ensure best results</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812861null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Excimer-laser-procedure-holds-appeal-in-younger-pa/ArticleStandard/Article/detail/812872?ref=25">

    <title>Excimer laser procedure holds appeal in younger patients</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Excimer-laser-procedure-holds-appeal-in-younger-pa/ArticleStandard/Article/detail/812872?ref=25</link>

    <description>PresbyLASIK offers advatages compared to inlays, according to Dr Tamayo</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812872null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Canaloplasty-An-alternative-to-filtrating-surgery/ArticleStandard/Article/detail/812868?ref=25">

    <title>Canaloplasty: An alternative to filtrating surgery</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Canaloplasty-An-alternative-to-filtrating-surgery/ArticleStandard/Article/detail/812868?ref=25</link>

    <description>Taking advantage of the other outflow pathways without requiring sub-conjunctival
    filtering</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812868null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/MIOL-implantation-in-paediatric-cases/ArticleStandard/Article/detail/812873?ref=25">

    <title>MIOL implantation in paediatric cases</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/MIOL-implantation-in-paediatric-cases/ArticleStandard/Article/detail/812873?ref=25</link>

    <description>A review of surgical results demonstrate safety</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812873null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Accuracy-of-wavefront-aberrometry-in-cataract-pati/ArticleStandard/Article/detail/812864?ref=25">

    <title>Accuracy of wavefront aberrometry in cataract patients</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Accuracy-of-wavefront-aberrometry-in-cataract-pati/ArticleStandard/Article/detail/812864?ref=25</link>

    <description>Loss of optical media transperency reduces accuracy in clinical practice</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812864null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Product-Profiles/ArticleStandard/Article/detail/812870?ref=25">

    <title>Product Profiles</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Product-Profiles/ArticleStandard/Article/detail/812870?ref=25</link>

    <description>A round-up of the latest ophthalmic products</description>

    <dc:date>2013-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/192013/812870null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Excellent-visual-outcomes-in-cataract-surgery/ArticleStandard/Article/detail/811396?ref=25">

    <title>Excellent visual outcomes in cataract surgery</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Excellent-visual-outcomes-in-cataract-surgery/ArticleStandard/Article/detail/811396?ref=25</link>

    <description>Cataract surgery produces excellent visual outcomes, with 61.3% of patients achieving a corrected
    distance visual acuity of 20/20 or better, according to a database study in the Journal of Cataract and Refractive
    Surgery.</description>

    <dc:date>2013-04-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/172013/811396null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Retina/NICE-recommends-ranibizumab-for-NHS/ArticleStandard/Article/detail/811395?ref=25">

    <title>NICE recommends ranibizumab for NHS</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Retina/NICE-recommends-ranibizumab-for-NHS/ArticleStandard/Article/detail/811395?ref=25</link>

    <description>Ranibizumab has been recommended for use within the NHS in England and Wales to treat macular oedema
    (ME) secondary to retinal vein occlusion (RVO).</description>

    <dc:date>2013-04-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/172013/811395null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Cornea/FS-laer-assisted-intrastomal-arcuate-keratotomy-a-/ArticleStandard/Article/detail/810803?ref=25">

    <title>FS-laer assisted intrastomal arcuate keratotomy a success</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Cornea/FS-laer-assisted-intrastomal-arcuate-keratotomy-a-/ArticleStandard/Article/detail/810803?ref=25</link>

    <description>Intrastromal arcuate keratotomy performed with a femtosecond (FS) laser has an excellent safety
    profile, rapid recovery and stability of vision, claims a new paper.</description>

    <dc:date>2013-04-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/162013/810803null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Dry+Eye/New-financing-round-for-dry-eye-portfolio/ArticleStandard/Article/detail/811563?ref=25">

    <title>New financing round for dry eye portfolio</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Dry+Eye/New-financing-round-for-dry-eye-portfolio/ArticleStandard/Article/detail/811563?ref=25</link>

    <description>Novaliq has secured &amp;amp;euro;13.9 million in a fifth round of financing for a dry eye
    portfolio.</description>

    <dc:date>2013-04-24T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/172013/811563null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/POAG-surgical-outcomes-affected-by-DM/ArticleStandard/Article/detail/810795?ref=25">

    <title>POAG surgical outcomes affected by DM</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/POAG-surgical-outcomes-affected-by-DM/ArticleStandard/Article/detail/810795?ref=25</link>

    <description>According to recently published data, POAG patients with diabetes mellitus (DM) undergoing primary
    trabeculectomy with MMC do not achieve the same long-term IOP control compared to patients without
    DM.</description>

    <dc:date>2013-04-24T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/162013/810795null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Bevacizumab-not-recommended-for-NAION/ArticleStandard/Article/detail/810794?ref=25">

    <title>Bevacizumab not recommended for NAION</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Bevacizumab-not-recommended-for-NAION/ArticleStandard/Article/detail/810794?ref=25</link>

    <description>Intravitreal bevacizumab is not recommended for the treatment of new onset Nonarteritic Anterior
    Ischemic Optic Neuropathy (NAION).</description>

    <dc:date>2013-04-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/162013/810794null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Global-agreement-signed/ArticleStandard/Article/detail/810793?ref=25">

    <title>Global agreement signed</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Global-agreement-signed/ArticleStandard/Article/detail/810793?ref=25</link>

    <description>Bausch + Lomb have signed a global agreement for the rights to distribute Leica's ophthalmic surgical
    microscopes.</description>

    <dc:date>2013-04-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/162013/810793null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Bevacizumab-regresses-abnormal-diabetic-neovascula/ArticleStandard/Article/detail/810239?ref=25">

    <title>Bevacizumab regresses abnormal diabetic neovascularization</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Bevacizumab-regresses-abnormal-diabetic-neovascula/ArticleStandard/Article/detail/810239?ref=25</link>

    <description>Intravitreal bevacizumab is well tolerated and causes the regression of abnormal diabetic
    neovascularization, according to recently published data.</description>

    <dc:date>2013-04-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152013/810239null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Pressure-sensitive-lens-tolerable-and-safe-for-24-/ArticleStandard/Article/detail/810238?ref=25">

    <title>Pressure-sensitive lens tolerable and safe for 24 hours</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Pressure-sensitive-lens-tolerable-and-safe-for-24-/ArticleStandard/Article/detail/810238?ref=25</link>

    <description>A new pressure-sensitive contact lens is tolerable and safe over a 24-hour wearing period for healthy
    subjects and glaucoma sufferers.</description>

    <dc:date>2013-04-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152013/810238null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Multifocal-diffractive-add-on-IOL-suitable-alterna/ArticleStandard/Article/detail/810229?ref=25">

    <title>Multifocal diffractive add-on IOL suitable alternative</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Multifocal-diffractive-add-on-IOL-suitable-alterna/ArticleStandard/Article/detail/810229?ref=25</link>

    <description>Multifocal diffractive add-on IOL is a suitable alternative to standard multifocal IOLs for sulcus
    fixation.</description>

    <dc:date>2013-04-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152013/810229null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Unoprostone-in-Phase-III-study-for-RP/ArticleStandard/Article/detail/810218?ref=25">

    <title>Unoprostone in Phase III study for RP</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Unoprostone-in-Phase-III-study-for-RP/ArticleStandard/Article/detail/810218?ref=25</link>

    <description>Unoprostone will begin patient enrolment for the Phase III clinical study for the treatment of
    retinitis pigmentosa (RP), claims the latest press release.</description>

    <dc:date>2013-04-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/152013/810218null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Big-bubble-size-can-be-safely-increased/ArticleStandard/Article/detail/809095?ref=25">

    <title>Big bubble size can be safely increased</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Big-bubble-size-can-be-safely-increased/ArticleStandard/Article/detail/809095?ref=25</link>

    <description>Undersized big-bubbles for DALK can safely be increased using blunt dissection for white-margin
    bubbles and ophthalmic viscosurgical device injection for clear-margin bubbles.</description>

    <dc:date>2013-04-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809095null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/PDT-reduces-choroidal-thickness/ArticleStandard/Article/detail/809094?ref=25">

    <title>PDT reduces choroidal thickness</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/PDT-reduces-choroidal-thickness/ArticleStandard/Article/detail/809094?ref=25</link>

    <description>Low-fluence photodynamic therapy (PDT) decreases subfoveal choroidal thickness (SFCT) in central
    serous chorioretinopathy (CSC), states a paper in the journal Eye.</description>

    <dc:date>2013-04-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809094null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Pupil-size-and-axial-length-affect-near-vision/ArticleStandard/Article/detail/809093?ref=25">

    <title>Pupil size and axial length affect near vision</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Pupil-size-and-axial-length-affect-near-vision/ArticleStandard/Article/detail/809093?ref=25</link>

    <description>Small pupil size and short axial length predict good near vision after phacoemulsification and
    monofocal IOL implantation.</description>

    <dc:date>2013-04-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809093null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Trabectome-alternative-for-glaucoma-surgery/ArticleStandard/Article/detail/809092?ref=25">

    <title>Trabectome alternative for glaucoma surgery</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Trabectome-alternative-for-glaucoma-surgery/ArticleStandard/Article/detail/809092?ref=25</link>

    <description>Trabectome, a device that ablates the arc of trabecular meshwork, is a safe and effective alternative
    to glaucoma surgery, according to a recent paper.</description>

    <dc:date>2013-04-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809092null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/MGD-management-needed-for-ocular-prosthesis-wearer/ArticleStandard/Article/detail/808937?ref=25">

    <title>MGD management needed for ocular prosthesis wearers</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/MGD-management-needed-for-ocular-prosthesis-wearer/ArticleStandard/Article/detail/808937?ref=25</link>

    <description>Ocular prosthesis wearers may require clinical assessment and management for meibomian gland
    dysfunction (MGD).</description>

    <dc:date>2013-04-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/132013/808937null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Multicomponent-IOL-provides-excellent-vision/ArticleStandard/Article/detail/808935?ref=25">

    <title>Multicomponent IOL provides excellent vision</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Multicomponent-IOL-provides-excellent-vision/ArticleStandard/Article/detail/808935?ref=25</link>

    <description>Multicomponent IOL implantation is safe, easy and provides excellent vision, according to a recent
    case series.</description>

    <dc:date>2013-04-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/132013/808935null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Event+List/119th-SFO-Congress/ArticleStandard/Article/detail/809056?ref=25">

    <title>119th SFO Congress</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Event+List/119th-SFO-Congress/ArticleStandard/Article/detail/809056?ref=25</link>

    <description>119th Congress of SFO will be held in Paris, France</description>

    <dc:date>2013-04-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809056null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Paediatrics/BTA-injections-can-treat-infantile-esotropia/ArticleStandard/Article/detail/808936?ref=25">

    <title>BTA injections can treat infantile esotropia</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Paediatrics/BTA-injections-can-treat-infantile-esotropia/ArticleStandard/Article/detail/808936?ref=25</link>

    <description>Botulinum toxin type A (BTA) injections, with or without sodium hyaluronate (SH), are effective and
    feasible for the treatment of infantile esotropia.</description>

    <dc:date>2013-04-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/132013/808936null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Congress-of-the-French-Society-of-Ophthalmology-md/ArticleStandard/Article/detail/809058?ref=25">

    <title>Congress of the French Society of Ophthalmology &amp;amp;mdash; SFO 2013</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Congress-of-the-French-Society-of-Ophthalmology-md/ArticleStandard/Article/detail/809058?ref=25</link>

    <description>SFO 2013</description>

    <dc:date>2013-04-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809058null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Improving-vitreoretinal-surgery/ArticleStandard/Article/detail/809329?ref=25">

    <title>Improving vitreoretinal surgery</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Improving-vitreoretinal-surgery/ArticleStandard/Article/detail/809329?ref=25</link>

    <description>Treating the aetiology of recurrent vitreous haemorrhage improves patient outcomes</description>

    <dc:date>2013-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809329null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Limiting-IOP-rise-in-laser-cataract-procedures/ArticleStandard/Article/detail/809335?ref=25">

    <title>Limiting IOP rise in laser cataract procedures</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Limiting-IOP-rise-in-laser-cataract-procedures/ArticleStandard/Article/detail/809335?ref=25</link>

    <description>Catalys Precision Laser System features particularly beneficial for compromised cataract
    patients</description>

    <dc:date>2013-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809335null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+features/Mastering-corneal-inlays/ArticleStandard/Article/detail/809319?ref=25">

    <title>Mastering corneal inlays</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/CatRef+features/Mastering-corneal-inlays/ArticleStandard/Article/detail/809319?ref=25</link>

    <description>Optimum centration of corneal inlays is vital for successful presbyopia correction</description>

    <dc:date>2013-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809319null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Product-Profiles/ArticleStandard/Article/detail/809888?ref=25">

    <title>Product Profiles</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Product-Profiles/ArticleStandard/Article/detail/809888?ref=25</link>

    <description>A round-up of the latest ophthalmic products</description>

    <dc:date>2013-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809888null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Anti-VEGF-therapy-for-the-treatment-of-glaucoma/ArticleStandard/Article/detail/809312?ref=25">

    <title>Anti-VEGF therapy for the treatment of glaucoma</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Anti-VEGF-therapy-for-the-treatment-of-glaucoma/ArticleStandard/Article/detail/809312?ref=25</link>

    <description>Early reports on off-label uses for anti-VEGFs are promising</description>

    <dc:date>2013-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809312null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Inlay-promising-for-presbyopia/ArticleStandard/Article/detail/809325?ref=25">

    <title>Inlay promising for presbyopia</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Inlay-promising-for-presbyopia/ArticleStandard/Article/detail/809325?ref=25</link>

    <description>Reading test results key is method to correct presbyopia in patients with emmetropia</description>

    <dc:date>2013-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809325null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Surgical-compensation-of-presbyopia-with-a-corneal/ArticleStandard/Article/detail/809338?ref=25">

    <title>Surgical compensation of presbyopia with a corneal inlay implantation</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Surgical-compensation-of-presbyopia-with-a-corneal/ArticleStandard/Article/detail/809338?ref=25</link>

    <description>Two-year results revealed of reading performance and patient satisfaction with KAMRA</description>

    <dc:date>2013-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809338null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+features/Femto-phaco-vs-traditional-phaco/ArticleStandard/Article/detail/809321?ref=25">

    <title>Femto phaco vs traditional phaco</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/CatRef+features/Femto-phaco-vs-traditional-phaco/ArticleStandard/Article/detail/809321?ref=25</link>

    <description>First clinical results in the Eye Hospital Bellevue Kiel, Germany</description>

    <dc:date>2013-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809321null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Retina+features/ME-treatment-benefits-according-to-duration-of-BRV/ArticleStandard/Article/detail/809332?ref=25">

    <title>ME treatment benefits according to duration of BRVO</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Retina+features/ME-treatment-benefits-according-to-duration-of-BRV/ArticleStandard/Article/detail/809332?ref=25</link>

    <description>Duration of disease should be considered when offering vein occlusion patient treatment</description>

    <dc:date>2013-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809332null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Preservative-free-preparation-may-improve-adherenc/ArticleStandard/Article/detail/809315?ref=25">

    <title>Preservative-free preparation may improve adherence</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Preservative-free-preparation-may-improve-adherenc/ArticleStandard/Article/detail/809315?ref=25</link>

    <description>Tafluprost 0.0015% is safe, effective and well-tolerated in routine clinical practice</description>

    <dc:date>2013-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809315null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+features/Fixed-combinations-in-POAG-and-OHT-patients/ArticleStandard/Article/detail/809316?ref=25">

    <title>Fixed combinations in POAG and OHT patients</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma+features/Fixed-combinations-in-POAG-and-OHT-patients/ArticleStandard/Article/detail/809316?ref=25</link>

    <description>An overview of trials comparing topical medical therapies</description>

    <dc:date>2013-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809316null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/High-resolution-aberrometry/ArticleStandard/Article/detail/809342?ref=25">

    <title>High-resolution aberrometry</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/High-resolution-aberrometry/ArticleStandard/Article/detail/809342?ref=25</link>

    <description>Even without refned nomograms, new-generation aberrometry is contributing to better
    results</description>

    <dc:date>2013-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809342null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Fenretinide-has-potential-for-GA/ArticleStandard/Article/detail/808938?ref=25">

    <title>Fenretinide has potential for GA</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Fenretinide-has-potential-for-GA/ArticleStandard/Article/detail/808938?ref=25</link>

    <description>Oral drug fenretinide has potential for the treatment of geographic atrophy (GA), but further studies
    are required.</description>

    <dc:date>2013-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/132013/808938null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Efficacy-of-LCS-compared-with-manual-techniques/ArticleStandard/Article/detail/809317?ref=25">

    <title>Efficacy of LCS compared with manual techniques</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Efficacy-of-LCS-compared-with-manual-techniques/ArticleStandard/Article/detail/809317?ref=25</link>

    <description>Cost remains a large disadvantage to femtosecond laser cataract surgery</description>

    <dc:date>2013-04-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/142013/809317null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Cornea/Mushroom-configuration-can-perform-corneal-cuts/ArticleStandard/Article/detail/808645?ref=25">

    <title>Mushroom configuration can perform corneal cuts</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Cornea/Mushroom-configuration-can-perform-corneal-cuts/ArticleStandard/Article/detail/808645?ref=25</link>

    <description>Femtosecond laser (FSL)-assisted mushroom configuration deep anterior lamellar keratoplasty (DALK) is
    reliable and reproducible, stated a recent noncomparative case series.</description>

    <dc:date>2013-03-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/122013/808645null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Risk-factors-for-esotropia-reoperation-revealed/ArticleStandard/Article/detail/808643?ref=25">

    <title>Risk factors for esotropia reoperation revealed</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/Risk-factors-for-esotropia-reoperation-revealed/ArticleStandard/Article/detail/808643?ref=25</link>

    <description>Underaction of the lateral rectus muscle could be a risk factor for reoperation of congenital
    esostropia, claims an investigation in the Journal of Pediatric Ophthalmology and Strabismus.</description>

    <dc:date>2013-03-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/122013/808643null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Eye-viscosity-increases-with-age/ArticleStandard/Article/detail/808642?ref=25">

    <title>Eye viscosity increases with age</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Eye-viscosity-increases-with-age/ArticleStandard/Article/detail/808642?ref=25</link>

    <description>According to a paper published in Clinical and Experimental Ophthalmology, loss of energy due to
    elastic hysteresis positively correlates with age, leading to the belief that eye viscosity increases with
    age.</description>

    <dc:date>2013-03-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/122013/808642null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Monitoring-glaucoma-progression-with-SLP/ArticleStandard/Article/detail/808646?ref=25">

    <title>Monitoring glaucoma progression with SLP</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Monitoring-glaucoma-progression-with-SLP/ArticleStandard/Article/detail/808646?ref=25</link>

    <description>SLP has excellent reproducibility and may be useful in monitoring glaucoma progression.</description>

    <dc:date>2013-03-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/122013/808646null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Caution-needed-for-full-correction-in-low-astigmat/ArticleStandard/Article/detail/808012?ref=25">

    <title>Caution needed for full correction in low astigmatism</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Caution-needed-for-full-correction-in-low-astigmat/ArticleStandard/Article/detail/808012?ref=25</link>

    <description>Caution should be used when considering full astigmatic correction for manifest cylinder of 0.5 D or
    less in myopic patients, according to the latest investigation in the Journal of Cataract and Refractive
    Surgery.</description>

    <dc:date>2013-03-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/112013/808012null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/ICRS-depth-less-than-expected-using-OCT/ArticleStandard/Article/detail/808005?ref=25">

    <title>ICRS depth less than expected using OCT</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/ICRS-depth-less-than-expected-using-OCT/ArticleStandard/Article/detail/808005?ref=25</link>

    <description>Depth of intrastromal corneal ring segments (ICRS) is less than expected in myopic patients when
    measured by OCT, claims a recent paper.</description>

    <dc:date>2013-03-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/112013/808005null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/EyeTechCare-secures-third-round-of-funding-for-Eye/ArticleStandard/Article/detail/808004?ref=25">

    <title>EyeTechCare secures third round of funding for EyeOP1</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/EyeTechCare-secures-third-round-of-funding-for-Eye/ArticleStandard/Article/detail/808004?ref=25</link>

    <description>EyeTechCare has secured ?10 million in a third round of funding for two international clinical trials
    for the EyeOP1 glaucoma treatment.</description>

    <dc:date>2013-03-19T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/112013/808004null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Retinal-implant-provides-artificial-sight-for-the-/ArticleStandard/Article/detail/808003?ref=25">

    <title>Retinal implant provides artificial sight for the blind</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Retinal-implant-provides-artificial-sight-for-the-/ArticleStandard/Article/detail/808003?ref=25</link>

    <description>Retinal prosthesis systems (RPS) enable patients with retinal dystrophies to identify letters and
    words, confirms a new study.</description>

    <dc:date>2013-03-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/112013/808003null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Laser-confocal-imaging-useful-for-AMD/ArticleStandard/Article/detail/807451?ref=25">

    <title>Laser confocal imaging useful for AMD</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Laser-confocal-imaging-useful-for-AMD/ArticleStandard/Article/detail/807451?ref=25</link>

    <description>Scanning laser ophthalmoscopy with a lateral confocal aperture could highlight subclinical drusen and
    aid in the progression of monitoring in AMD patients, claims the latest paper in the British Journal of
    Ophthalmology.</description>

    <dc:date>2013-03-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807451null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Vision-UK-2013-speakers-announced/ArticleStandard/Article/detail/807450?ref=25">

    <title>Vision UK 2013 speakers announced</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Vision-UK-2013-speakers-announced/ArticleStandard/Article/detail/807450?ref=25</link>

    <description>The Vision UK 2013 conference, on the 11 June, has confirmed several key speakers, announced the UK
    Vision Strategy.</description>

    <dc:date>2013-03-13T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807450null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Aciex-and-Portola-enter-into-research-agreement/ArticleStandard/Article/detail/807447?ref=25">

    <title>Aciex and Portola enter into research agreement</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Aciex-and-Portola-enter-into-research-agreement/ArticleStandard/Article/detail/807447?ref=25</link>

    <description>Aciex Therapeutics and Portola Pharmaceuticals have entered into a collaborative agreement to develop
    drugs for the treatment of topical ophthalmic diseases, according to the latest press release.</description>

    <dc:date>2013-03-12T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807447null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/POAG-detection-successful-with-tract-based-spatial/ArticleStandard/Article/detail/807446?ref=25">

    <title>POAG detection successful with tract-based spatial imaging</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/POAG-detection-successful-with-tract-based-spatial/ArticleStandard/Article/detail/807446?ref=25</link>

    <description>Tract-based spatial statistical analysis of diffusion tensor imaging is a successful tool for the
    detection of cortical nerve fibre loss in primary open-angle glaucoma (POAG) patients, claims a recent
    paper.</description>

    <dc:date>2013-03-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807446null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Cornea/OSST-should-be-closely-monitored-for-rejection/ArticleStandard/Article/detail/806766?ref=25">

    <title>OSST should be closely monitored for rejection</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Cornea/OSST-should-be-closely-monitored-for-rejection/ArticleStandard/Article/detail/806766?ref=25</link>

    <description>Ocular surface stem cell transplantation (OSST) patients should be closely monitored for rejection and
    compliance with immunosuppression.</description>

    <dc:date>2013-03-07T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/092013/806766null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/ECD-not-linked-to-CCT-in-keratoconus/ArticleStandard/Article/detail/806762?ref=25">

    <title>ECD not linked to CCT in keratoconus</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/CatRef+news/ECD-not-linked-to-CCT-in-keratoconus/ArticleStandard/Article/detail/806762?ref=25</link>

    <description>Corneal endothelial cell density (ECD) changes are independent from central corneal thickness (CCT) in
    keratoconus patients, states a recent paper.</description>

    <dc:date>2013-03-06T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/092013/806762null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/PED-volume-and-area-changes-could-indicate-retreat/ArticleStandard/Article/detail/806761?ref=25">

    <title>PED volume and area changes could indicate retreatment</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/PED-volume-and-area-changes-could-indicate-retreat/ArticleStandard/Article/detail/806761?ref=25</link>

    <description>Volume and area changes in retinal pigment epithelial detachments (PEDs) could indicate the need for
    retreatment in eyes undergoing SD-OCT guided anti-VEGF therapy.</description>

    <dc:date>2013-03-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/092013/806761null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Supplements/Products-in-Practice-2013/ArticleStandard/Article/detail/807303?ref=25">

    <title>Products in Practice 2013</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Supplements/Products-in-Practice-2013/ArticleStandard/Article/detail/807303?ref=25</link>

    <description>Real world experience of leading ophthalmic products - issue 2</description>

    <dc:date>2013-03-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807303null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/High-patient-satisfaction-for-ocular-hypotensives/ArticleStandard/Article/detail/806759?ref=25">

    <title>High patient satisfaction for ocular hypotensives</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/High-patient-satisfaction-for-ocular-hypotensives/ArticleStandard/Article/detail/806759?ref=25</link>

    <description>Glaucoma and ocular hypertension (OHT) patients are highly satisfied with ocular hypertensives, claims
    a recent investigation.</description>

    <dc:date>2013-03-04T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/092013/806759null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Moving-forwards-noninvasive-imaging-of-the-eye/ArticleStandard/Article/detail/807271?ref=25">

    <title>Moving forwards: noninvasive imaging of the eye</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Moving-forwards-noninvasive-imaging-of-the-eye/ArticleStandard/Article/detail/807271?ref=25</link>

    <description>US pachymetry offers no advantage over optical noncontact methods, according to Dr
    Savini</description>

    <dc:date>2013-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807271null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/SMILE-techniques-less-disruptive/ArticleStandard/Article/detail/807276?ref=25">

    <title>SMILE techniques less disruptive</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/SMILE-techniques-less-disruptive/ArticleStandard/Article/detail/807276?ref=25</link>

    <description>Corneal biomechanical stability is better, less affected by flapless refractive
    procedure</description>

    <dc:date>2013-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807276null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Devices-Adapted-to-CMICS-phaco/ArticleStandard/Article/detail/807278?ref=25">

    <title>Devices Adapted to CMICS phaco</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Devices-Adapted-to-CMICS-phaco/ArticleStandard/Article/detail/807278?ref=25</link>

    <description>Study shows reproducibility with devices dedicated to standardizing capsulorhexis</description>

    <dc:date>2013-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807278null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/MICS-and-TSV-Combined/ArticleStandard/Article/detail/807279?ref=25">

    <title>MICS and TSV Combined</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/MICS-and-TSV-Combined/ArticleStandard/Article/detail/807279?ref=25</link>

    <description>Doube optimization for improved solutions</description>

    <dc:date>2013-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807279null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Scheimpflug-tomographers-Are-they-precise/ArticleStandard/Article/detail/807275?ref=25">

    <title>Scheimpflug tomographers: Are they precise?</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Scheimpflug-tomographers-Are-they-precise/ArticleStandard/Article/detail/807275?ref=25</link>

    <description>Comparative data demonstrates good agreement between devices</description>

    <dc:date>2013-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807275null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/A-genetic-algorithm-to-predict-the-risk-of-advance/ArticleStandard/Article/detail/807281?ref=25">

    <title>A genetic algorithm to predict the risk of advanced AMD</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/A-genetic-algorithm-to-predict-the-risk-of-advance/ArticleStandard/Article/detail/807281?ref=25</link>

    <description>New clinical approach targeted to early detection</description>

    <dc:date>2013-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807281null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Topography-guided-ablation-for-myopia-and-myopic-a/ArticleStandard/Article/detail/807282?ref=25">

    <title>Topography-guided ablation for myopia and myopic astigmatism</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Topography-guided-ablation-for-myopia-and-myopic-a/ArticleStandard/Article/detail/807282?ref=25</link>

    <description>Study outcomes demonstrate feasibility of technique as primary treatment</description>

    <dc:date>2013-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807282null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/En-face-OCT-imaging-takes-shape/ArticleStandard/Article/detail/807274?ref=25">

    <title>En-face OCT imaging takes shape</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/En-face-OCT-imaging-takes-shape/ArticleStandard/Article/detail/807274?ref=25</link>

    <description>Technology appears to be useful, necessary complement to cross-sectional B-scans</description>

    <dc:date>2013-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807274null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Comparison-of-PCO-Between-a-1--and-3-Piece-MICS-IO/ArticleStandard/Article/detail/807280?ref=25">

    <title>Comparison of PCO Between a 1- and 3-Piece MICS IOL</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Comparison-of-PCO-Between-a-1--and-3-Piece-MICS-IO/ArticleStandard/Article/detail/807280?ref=25</link>

    <description>Modifications of haptic design yields benefits</description>

    <dc:date>2013-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807280null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Retro-foveolar-choroidal-thickness-is-thinner-in-a/ArticleStandard/Article/detail/807277?ref=25">

    <title>Retro-foveolar choroidal thickness is thinner in angle closure glaucoma eyes</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Retro-foveolar-choroidal-thickness-is-thinner-in-a/ArticleStandard/Article/detail/807277?ref=25</link>

    <description>Is there a correlation between choroidal thickness and certain types of glaucoma</description>

    <dc:date>2013-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807277null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Retinal-layer-thickness-is-decreased-in-glaucomato/ArticleStandard/Article/detail/807273?ref=25">

    <title>Retinal layer thickness is decreased in glaucomatous eyes</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Retinal-layer-thickness-is-decreased-in-glaucomato/ArticleStandard/Article/detail/807273?ref=25</link>

    <description>The thickness of several different layers of the retina is reduced in eyes with glaucoma</description>

    <dc:date>2013-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807273null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Product-Profiles/ArticleStandard/Article/detail/807272?ref=25">

    <title>Product Profiles</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Product-Profiles/ArticleStandard/Article/detail/807272?ref=25</link>

    <description>A round-up of the latest ophthalmic products</description>

    <dc:date>2013-03-01T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/102013/807272null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/A-P-method-may-calculate-IOL-power/ArticleStandard/Article/detail/806066?ref=25">

    <title>A-P method may calculate IOL power</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/A-P-method-may-calculate-IOL-power/ArticleStandard/Article/detail/806066?ref=25</link>

    <description>The anterior-posterior (A-P) method is effective for calculating IOL power when preoperative LASIK
    data is unavailable.</description>

    <dc:date>2013-02-28T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/082013/806066null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Aflibercept-injections-improves-VA-in-CRVO-patient/ArticleStandard/Article/detail/806065?ref=25">

    <title>Aflibercept injections improves VA in CRVO patients</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Aflibercept-injections-improves-VA-in-CRVO-patient/ArticleStandard/Article/detail/806065?ref=25</link>

    <description>Monthly intravitreal aflibercept significantly improves visual acuity (VA) in patients with macular
    oedema secondary to central retinal vein occlusion (CRVO), according to the latest phase of the COPERNICUS
    study.</description>

    <dc:date>2013-02-27T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/082013/806065null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Vision-UK-2013-call-for-papers/ArticleStandard/Article/detail/806105?ref=25">

    <title>Vision UK 2013 call for papers</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Vision-UK-2013-call-for-papers/ArticleStandard/Article/detail/806105?ref=25</link>

    <description>The UK Vision Strategy has opened a call for posters and abstracts for the Vision UK 2013
    conference.</description>

    <dc:date>2013-02-27T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/082013/806105null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Clobetasone-butyrate-safe-and-effective-for-SS/ArticleStandard/Article/detail/806064?ref=25">

    <title>Clobetasone butyrate safe and effective for SS</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Clobetasone-butyrate-safe-and-effective-for-SS/ArticleStandard/Article/detail/806064?ref=25</link>

    <description>Low doses of clobetasone butyrate drops are safe and effective for Sj?gren syndrome (SS), claims an
    investigation.</description>

    <dc:date>2013-02-26T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/082013/806064null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Coats-disease-treated-with-bevacizumab/ArticleStandard/Article/detail/806063?ref=25">

    <title>Coats' disease treated with bevacizumab</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Coats-disease-treated-with-bevacizumab/ArticleStandard/Article/detail/806063?ref=25</link>

    <description>Bevacizumab could play a role in treating Coats' disease, claims a recent study.</description>

    <dc:date>2013-02-25T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/082013/806063null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Loteprednol-etabonate-controls-inflammation-and-IO/ArticleStandard/Article/detail/805647?ref=25">

    <title>Loteprednol etabonate controls inflammation and IOP</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/CatRef+clinical/Loteprednol-etabonate-controls-inflammation-and-IO/ArticleStandard/Article/detail/805647?ref=25</link>

    <description>Loteprednol etabonate controls inflammation and reduces IOP fluctuation after cataract surgery,
    according to a recent study.</description>

    <dc:date>2013-02-21T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/072013/805647null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Beclomethasone-nasal-spray-doesnt-increase-IOP/ArticleStandard/Article/detail/805646?ref=25">

    <title>Beclomethasone nasal spray doesn't increase IOP</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Glaucoma/Beclomethasone-nasal-spray-doesnt-increase-IOP/ArticleStandard/Article/detail/805646?ref=25</link>

    <description>Beclomethasone nasal spray doesn't increase IOP in patients with ocular hypertension and primary
    open-angle glaucoma, reveals a study in the Journal of Glaucoma.</description>

    <dc:date>2013-02-20T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/072013/805646null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/ICG-enhanced-TTT-effectively-treats-retinoblastoma/ArticleStandard/Article/detail/805645?ref=25">

    <title>ICG-enhanced TTT effectively treats retinoblastoma</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/ICG-enhanced-TTT-effectively-treats-retinoblastoma/ArticleStandard/Article/detail/805645?ref=25</link>

    <description>Indocyanine green (ICG) enhanced transpupillary thermotherapy (TTT) in combination with ophthalmic
    artery chemosurgery can effectively treat retinoblastoma refractory without ocular side effects, claims a
    study.</description>

    <dc:date>2013-02-19T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/072013/805645null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Strategic-alliance-for-clinical-research-announced/ArticleStandard/Article/detail/805644?ref=25">

    <title>Strategic alliance for clinical research announced</title>

    <link>
    http://www.oteurope.com/ophthalmologytimeseurope/Latest+News/Strategic-alliance-for-clinical-research-announced/ArticleStandard/Article/detail/805644?ref=25</link>

    <description>Research Dynamics Consulting Group and ClinROC LLC have announced a strategic alliance to provide
    clinical research and product development services for the ophthalmic industry.</description>

    <dc:date>2013-02-18T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://www.oteurope.com/ophthalmologytimeseurope/data/articlestandard/ophthalmologytimeseurope/072013/805644null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>
</rdf:RDF>


